Search results
Results From The WOW.Com Content Network
Dagsrevyen (English: The Daily Review) is the daily evening news programme for the Norwegian television channel NRK1, the main channel of the Norwegian Broadcasting Corporation (NRK), broadcast at 7 pm.
NRK1 eventually turned full-time HD, with the separate SD feeds shutting down approximately in 2016. The programming lineup has varied over the years, with an increased focus on daytime news beginning in the 2020s, with newscasts almost uninterrupted from 06:30-20:00 on weekdays.
This is a list of some programs that have been or are being broadcast by Norwegian Broadcasting Corporation (NRK) (Norwegian: Norsk rikskringkasting) on the NRK1, NRK2, NRK3 or NRK Super television channels. Included are national radio programs. The list is incomplete. There may be many years ago that the programs were shown.
NRK1; NRK2; NRK3 (Youth channel); NRK Super (Children channel); NRK Tegnspråk (Television channel for those with a hearing impairment. This channel adapts shows from the other national channels, so that they are appropriate for those with hearing loss, for example by adding sign language and/or subtitles)
NRK has 12 regional offices around Norway. Each office has its own broadcasts on both television (on NRK 1) and radio (on NRK P1), as well their own news sites on the internet. They also contribute news coverage to national news programmes. NRK's headquarters are at Marienlyst in Oslo and Tyholt in Trondheim.
Emiliano Grillo set off the latest beer shower at the Phoenix Open with an ace on the stadium 16th hole. Grillo's shot on the 155-yard hole flew directly into the cup and swirled around a few ...
NRK1 goes out to 99,8% of all households, while TV2 has a 92% coverage and NRK2 and NRK3/NRK Super has 80% coverage. There are today 24 local television channels in the country, all terrestrially transmitted. The first local channel, TVBudstikka was started in 1986.
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye ...